Virtual Medicinal Product (VMP)
-
Mepolizumab 100mg powder for solution for injection vials
Name Details
Current Name
Mepolizumab 100mg powder for solution for injection vials
|
Start Date
07-01-2016
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Powder for solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
R03DX09
BNF |
Current BNF
03040200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
03040200
|
Start Date
27-03-2017
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
31210311000001108 |
07-01-2016 |
|
VMP Ingredients
VMP ingredients table
Mepolizumab |
Based on Ingredient Substance |
|
100 mg |
|
Name
Mepolizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Mepolizumab
-
VMP
(Current) Mepolizumab 100mg powder for solutio...
Virtual Medicinal Product Pack (VMPP) Information